The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

A Cramlington mum who was diagnosed with cancer six weeks after giving birth to her second child says that "making memories ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

John Heymach, MD, PhD, The University of Texas MD Anderson Cancer Center, discusses the promising results of zongertinib for HER2-mutated non–small cell lung cancer, showcasing high response rates and ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

A BRAVE mum is refusing to let terminal lung cancer slow her down as she runs in today’s London Marathon. For Emma Philp, 36, ...

The father of a young woman who had her grave targeted by Islamophobic criminals has spoken of his "incredible sadness".

A chilling new study from researchers at the Rutgers Cancer Institute found terminal cancer patients rarely make major ...

A sobering study conducted by researchers at the Rutgers Cancer Institute has revealed that decisions made by patients with ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...